News

The Malaysian Reserve8h
SABRE topline results: Cu-64 SAR-Bombesin is effective in detecting prostate cancer recurrence in patients with negative SOC imaging
Highlights Topline data from Clarity's diagnostic Phase II trial, SABRE, showed that 64Cu-SAR-Bombesin was safe, well ...
The atomic answer to cancer and beyond
This article is authored by Dr Baljinder Singh, professor, Department of Nuclear Medicine, PGIMER, Chandigarh.